Theory and practice of immunoregulatory therapy with traditional Chinese medicine for chronic hepatitis B
10.3969/j.issn.1001-5256.2023.12.023
- VernacularTitle:慢性乙型肝炎中医药免疫调控治疗的理论与实践
- Author:
Xiaobin LI
1
;
Bowen LIU
1
;
Feng LI
1
;
Xiaopeng SU
1
;
Shiping HU
2
Author Information
1. Beijing University of Chinese Medicine， Beijing 100029， China
2. Shenzhen Hospital Affiliated to Beijing University of Chinese Medicine， Shenzhen， Guangdong 518172， China
- Publication Type:Review
- Keywords:
Hepatitis B， Chronic;
Traditional Chinese Medicine Therapy;
Immunotherapy
- From:
Journal of Clinical Hepatology
2023;39(12):2908-2913
- CountryChina
- Language:Chinese
-
Abstract:
Chronic hepatitis B （CHB） is still a malignant infectious disease that seriously threatens human health， and currently nucleos（t）ide analogues and interferon are the main treatment methods for CHB， but they cannot achieve functional cure. The development and progression of CHB are closely associated with immune function dysregulation in the host， and therefore， regulating host immunity has become a key link in the treatment of CHB. Recent studies have shown that traditional Chinese medicine exerts a therapeutic effect on CHB by regulating host immune function. This article introduces the relationship between traditional Chinese medicine theory and immunity and summarizes the theoretical basis and related studies for traditional Chinese medicine in the immune regulation of CHB， in order to provide new ideas for integrated traditional Chinese and Western medicine therapy for CHB.
